Grupo Fleury

About Grupo Fleury

Grupo Fleury is recognized as a benchmark for quality in diagnostic medicine in the country, with complete solutions, individual-centered care coordination, innovation capacity, and technology. We have an integrated, preventive, and hybrid health portfolio. We were born as a laboratory and have evolved to offer complete diagnostic medicine solutions across service units, B2B operations, and Lab-to-Lab. Currently, the Group combines physical and digital offerings, integrating diagnostic medicine, a health platform, and new links in the healthcare chain, with a broad portfolio of services in different specialties such as medication infusion, reproductive medicine, orthopedics, ophthalmology, outpatient surgical centers, and oncology. The company has practiced the best ESG practices since its foundation, almost 100 years ago, always acting proactively, exercising a conscious organizational culture that understands the cycle of impacts generated. More than that, it has been evolving its set of practices, maintaining the purpose of expanding access to health, bringing quality and a portfolio of services and solutions to more and more Brazilians. Grupo Fleury is made up of a team of over 27,000 people. We are present (in the B2C segment) in 13 states and the Federal District, with more than 500 Service Units. We remain engaged in our ambition: to strengthen ourselves as one of the healthcare leaders in Brazil through increasingly complete, integrated, and sustainable solutions and experiences in people's health and well-being journey.